PurposeThis study aimed to elucidate the effects magnesium stearate (MgSt) with different physical properties have on powder flow and tablet physical properties. The effects of variation in MgSt chemical properties were also investigated with a focus on the palmitate to stearate (C16/C18) ratio.MethodsLactose blended with 0.25, 0.5 and 1%, w/w of different MgSt grades were evaluated for flow properties. Tablets produced from the mixtures were assessed for tensile strength and ejection force.ResultsPearson correlation analysis of high C16/C18 ratio (1.09-1.29) MgSt suggested that increasing C16/C18 ratio could improve flowability and reduce tablet mechanical strength. For low C16/C18 ratio (0.41-0.53) MgSt, increasing C16/C18 ratio only resulted in better flowability. Multivariate analysis showed that the MgSt properties influenced the flowability and tablet physical properties of formulations containing 1%, w/w MgSt. The C16/C18 ratio affected flowability. However, its effect was confounded by MgSt particle size, morphology, crystallinity, and moisture content. Contrastingly, tablet tensile strength was mainly influenced by MgSt particle size, crystallinity, and moisture content, while tablet ejection force was minimally affected by the MgSt properties.ConclusionWhile the C16/C18 ratio could affect the powder flow properties, the effect was confounded by other MgSt properties. The C16/C18 ratio also had minimal effect on tablet physical properties. The results further showed that although MgSt with smaller particle size, higher crystallinity and moisture content provided better flowability, the resultant tablets had lower tensile strength. These findings highlighted the importance of MgSt properties for formulations of good flowability and tablet physical properties.
机构:
Univ Ljubljana, Dept Pharmaceut Technol, Fac Pharm, Ljubljana 1000, SloveniaUniv Ljubljana, Dept Pharmaceut Technol, Fac Pharm, Ljubljana 1000, Slovenia
Sibanc, Rok
Kitak, Teja
论文数: 0引用数: 0
h-index: 0
机构:
Univ Ljubljana, Dept Pharmaceut Technol, Fac Pharm, Ljubljana 1000, SloveniaUniv Ljubljana, Dept Pharmaceut Technol, Fac Pharm, Ljubljana 1000, Slovenia
Kitak, Teja
Govedarica, Biljana
论文数: 0引用数: 0
h-index: 0
机构:
Univ Ljubljana, Dept Pharmaceut Technol, Fac Pharm, Ljubljana 1000, SloveniaUniv Ljubljana, Dept Pharmaceut Technol, Fac Pharm, Ljubljana 1000, Slovenia
Govedarica, Biljana
Srcic, Stanko
论文数: 0引用数: 0
h-index: 0
机构:
Univ Ljubljana, Dept Pharmaceut Technol, Fac Pharm, Ljubljana 1000, SloveniaUniv Ljubljana, Dept Pharmaceut Technol, Fac Pharm, Ljubljana 1000, Slovenia
Srcic, Stanko
Dreu, Rok
论文数: 0引用数: 0
h-index: 0
机构:
Univ Ljubljana, Dept Pharmaceut Technol, Fac Pharm, Ljubljana 1000, SloveniaUniv Ljubljana, Dept Pharmaceut Technol, Fac Pharm, Ljubljana 1000, Slovenia
机构:
Univ Fed Rio de Janeiro, Fac Pharm, Rio De Janeiro, BrazilTrinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Synth & Solid State Pharmaceut Ctr, Dublin, Ireland
机构:
Eli Lilly & Co, Pharmaceut Sci Res & Dev, Lilly Res Labs, Indianapolis, IN 46285 USAEli Lilly & Co, Pharmaceut Sci Res & Dev, Lilly Res Labs, Indianapolis, IN 46285 USA
Risley, Donald S.
Magnusson, Lars-Erik
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Pharmaceut Sci Res & Dev, Lilly Res Labs, Indianapolis, IN 46285 USAEli Lilly & Co, Pharmaceut Sci Res & Dev, Lilly Res Labs, Indianapolis, IN 46285 USA
Magnusson, Lars-Erik
Morow, Paul R.
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Pharmaceut Sci Res & Dev, Lilly Res Labs, Indianapolis, IN 46285 USAEli Lilly & Co, Pharmaceut Sci Res & Dev, Lilly Res Labs, Indianapolis, IN 46285 USA
Morow, Paul R.
Aburub, Aktham
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Pharmaceut Sci Res & Dev, Lilly Res Labs, Indianapolis, IN 46285 USAEli Lilly & Co, Pharmaceut Sci Res & Dev, Lilly Res Labs, Indianapolis, IN 46285 USA